Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. Outdated funding lapse notices and operating-status messages tied to earlier revisions (v3.4.1) were removed.
    Difference
    0.2%
    Check dated 2026-02-11T14:11:48.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a government funding notice regarding operations and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:22:20.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Additions: Show glossary UI element; new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. Deletions: remove 'Last Update Submitted that met QC Criteria' (lowercase 'met'), 'No FEAR Act data', and the older Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T06:11:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 updated on the page, replacing v3.3.3. This appears to be a non-substantive, cosmetic update that does not alter study details or eligibility.
    Difference
    0.0%
    Check dated 2026-01-14T03:29:36.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The study’s Locations list has been expanded to include numerous additional sites across the United States and internationally (including several states and regions in Belgium, Korea, and Taiwan), and the page shows a revision tag v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T20:40:58.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Publication notes under PubMed now state that publications are automatically filled from PubMed, and the footer revision number changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:52:24.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.